Le Lézard
Classified in: Health
Subject: MAT

US Fertility partner practice Shady Grove Fertility (SGF) welcomes Dr. Benjamin S. Harris to expand access to world-class fertility care in Richmond and Norfolk


Benjamin S. Harris, M.D., M.P.H., is now accepting new patient appointments at SGF Richmond's Stony Point and Henrico Doctors'-Forest locations as well as SGF Jones Institute's Norfolk, Virginia location.

RICHMOND, Va., Sept. 28, 2022 /PRNewswire-PRWeb/ -- US Fertility, the nation's largest partnership of physician-owned and physician-led top-tier fertility practices, welcomes Benjamin S. Harris, M.D., to SGF Richmond's Stony Point and Henrico Doctors'-Forest locations as well as SGF Jones Institute's Norfolk, Virginia, location. Dr. Harris is now scheduling new patient appointments.

"SGF puts the patient first," shares Dr. Harris. "The foundation of our practice is based on doing what is best for our patients, promoting a strong patient-physician relationship, and promoting teamwork through collaborative care. We are constantly striving to improve the care we provide through education, research, and innovation. In doing so, we can enhance the experience of every single patient as we work toward achieving their fertility goals."

To address the high demand in the region for top-quality fertility care, Dr. Harris will provide comprehensive fertility services, including:

Dr. Harris is board certified in obstetrics and gynecology (OB/GYN) and board eligible in reproductive endocrinology and infertility (REI). Dr. Harris earned his medical degree and Master of Public Health from the University of North Carolina at Chapel Hill. He then completed his residency training in OB/GYN at Duke University Medical Center in Durham, North Carolina, where he was an Administrative Chief Resident. From there, Dr. Harris continued his training at Duke University Medical Center to complete his fellowship in REI.

As an avid researcher, Dr. Harris has contributed to numerous publications and presentations exploring such topics as fibroids, in vitro fertilization (IVF) protocols, reproductive epidemiology, and preimplantation genetic testing.    

"By welcoming Dr. Harris to the SGF physician team in Richmond and Norfolk, we're able to expand access to those in need of fertility care in Richmond and Norfolk," shares Erika B. Johnston-MacAnanny, M.D., Medical Director, SGF Richmond. "Dr. Harris's dedication to working together with patients to achieve their goals through providing a collaborative and educational experience directly aligns with SGF's mission to provide patient-centered fertility care."

Patients may now schedule a new patient appointment with Dr. Harris by calling the SGF New Patient Center at 757-512-8547 or by completing this brief form.

About US Fertility
US Fertility?is the nation's largest partnership of physician-owned and physician-led top-tier fertility practices, offering comprehensive fertility-market-focused non-clinical, administrative, and technical platforms that help domestic and international practices improve patient outcomes and increase patient access. To learn more about partnership- or affiliate-status benefits, call 301-545-1308 or visit?USFertility.com.

About Shady Grove Fertility (SGF)
SGF is a leading fertility and IVF center of excellence with more than 100,000 babies born from 30+ years of continuous innovation and patient-centered fertility care. With 50 locations, including the newest location in Raleigh, North Carolina, as well as throughout CO, FL, GA, MD, NY, PA, TX, VA, D.C., and Santiago, Chile, SGF offers patients in-person and virtual physician consults, delivers individualized care, accepts most insurance plans, and makes treatment affordable through innovative financial options, including 100% refund guarantees. SGF is among the founding partner practices of US Fertility, the largest physician-led partnership of top-tier fertility practices in the U.S. Call 1-888-761-1967 to schedule a new patient appointment or visit ShadyGroveFertility.com for more information.

Media Contact

Jean Dzierzak, US Fertility, 301-545-1375, [email protected]

 

SOURCE Shady Grove Fertility


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: